News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,376 Results
Type
Article (41701)
Company Profile (278)
Press Release (681387)
Multimedia
Podcasts (84)
Webinars (17)
Section
Business (205144)
Career Advice (2050)
Deals (35594)
Drug Delivery (110)
Drug Development (81547)
Employer Resources (174)
FDA (16432)
Job Trends (15015)
News (347115)
Policy (32780)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2597)
Accelerated approval (32)
Adcomms (25)
Allergies (137)
Alliances (49727)
ALS (170)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (307)
Approvals (16694)
Artificial intelligence (503)
Autoimmune disease (143)
Automation (37)
Bankruptcy (362)
Best Places to Work (11692)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (182)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4752)
Cardiovascular disease (395)
Career advice (1731)
Career pathing (35)
CAR-T (276)
CDC (45)
Celiac Disease (2)
Cell therapy (731)
Cervical cancer (36)
Clinical research (69597)
Collaboration (1675)
Company closure (4)
Compensation (1138)
Complete response letters (53)
COVID-19 (2715)
CRISPR (88)
C-suite (817)
Cystic fibrosis (143)
Data (6150)
Decentralized trials (2)
Denatured (26)
Depression (138)
Diabetes (495)
Diagnostics (6674)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90103)
Editorial (56)
Employer branding (22)
Employer resources (152)
Events (117512)
Executive appointments (962)
FDA (19511)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1455)
Gene editing (192)
Generative AI (42)
Gene therapy (584)
GLP-1 (969)
Government (4670)
Grass and pollen (6)
Guidances (383)
Healthcare (18913)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (246)
Immuno-oncology (53)
Indications (103)
Infectious disease (2973)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (243)
Interviews (324)
IPO (16659)
IRA (49)
Job creations (3663)
Job search strategy (1445)
JPM (58)
Kidney cancer (15)
Labor market (83)
Layoffs (548)
Leadership (31)
Legal (7962)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (778)
MASH (161)
Medical device (13780)
Medtech (13832)
Mergers & acquisitions (19990)
Metabolic disorders (1254)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (320)
Neuropsychiatric disorders (91)
Neuroscience (2925)
Neurotech (1)
NextGen: Class of 2026 (6556)
Non-profit (4528)
Now hiring (65)
Obesity (589)
Opinion (258)
Ovarian cancer (164)
Pain (200)
Pancreatic cancer (222)
Parkinson's disease (287)
Partnered (33)
Patents (487)
Patient recruitment (471)
Peanut (55)
People (58991)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21697)
Phase 2 (30631)
Phase 3 (22817)
Pipeline (5079)
Policy (280)
Postmarket research (2568)
Preclinical (9229)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (818)
Real estate (5983)
Recruiting (69)
Regulatory (24447)
Reports (51)
Research institute (2407)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (150)
Series A (241)
Series B (187)
Service/supplier (11)
Sickle cell disease (95)
Special edition (24)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3639)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (56)
Vaccines (985)
Venture capital (87)
Weight loss (378)
Women's health (87)
Worklife (18)
Date
Today (14)
Last 7 days (591)
Last 30 days (2219)
Last 365 days (29885)
2026 (2823)
2025 (30278)
2024 (35314)
2023 (40179)
2022 (51266)
2021 (55818)
2020 (54187)
2019 (46644)
2018 (35129)
2017 (32198)
2016 (31620)
2015 (37692)
2014 (31466)
2013 (26494)
2012 (28684)
2011 (29384)
2010 (27420)
Location
Africa (745)
Alabama (83)
Alaska (7)
Arizona (307)
Arkansas (13)
Asia (39356)
Australia (6444)
California (11167)
Canada (3251)
China (1089)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84941)
Florida (1663)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (866)
India (63)
Indiana (514)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (8021)
Michigan (320)
Minnesota (623)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2969)
New Mexico (28)
New York (2949)
North Carolina (1435)
North Dakota (8)
Northern California (5441)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2255)
Puerto Rico (22)
Rhode Island (47)
South America (1111)
South Carolina (65)
South Dakota (1)
Southern California (4341)
Tennessee (173)
Texas (1721)
United States (39633)
Utah (334)
Vermont (1)
Virginia (256)
Washington D.C. (82)
Washington State (916)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
723,376 Results for "gate neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
·
5 min read
Press Releases
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
November 14, 2025
·
4 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia
December 4, 2025
·
3 min read
Press Releases
Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies
August 15, 2025
·
3 min read
Press Releases
Apollo Neuroscience Announces 2025 Year in Review
February 2, 2026
·
6 min read
Press Releases
Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate Medicines
July 25, 2025
·
2 min read
Gate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting
Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.
May 15, 2024
·
4 min read
Press Releases
Klotho Neurosciences to Present at the Biotech Showcase 2026
January 8, 2026
·
2 min read
1 of 72,338
Next
